how long to hold glp 1 prior to surgery American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors Does It Matter Where You
Description
February 16, 2024
GLP-1 stimulates the -cells to produce Insulin, blocks pancreatic -cells' glucagon release via somatostatin (96), slows down gastric emptying (131), improves peripheral glucose tolerance (132), suppresses appetite in the hypothalamus and amygdala (97), increases -cell mass, GSIS, and elicits protection from glucolipotoxicity (133) and apoptosis (134)
[Abstract]2024 May 3:2024.05.01.591950
How tirzepatide compares to other GLP-1 medications Tirzepatide is a dual GIP and GLP-1 receptor agonist, which distinguishes it from pure GLP-1 drugs like semaglutide
Additionally, liraglutide was linked to a relative risk of 12.52 for acute cholecystitis , though this wasnt statistically significant across all patient groups
